In conclusion, we optimized a peptide using in silico tools to obtain a potent and competitive inhibitor of BACE-1, which is able to distribute and permeate the brain–blood barrier without causing any toxicity in mice and is useful for the treatment of amyloid-linked neurodegenerative diseases. Here, BACE1 is linked to amyloidosis.